癌症治疗后的心脏毒性
Cardiotoxicity Following Cancer Treatment.
作者信息
Walls G M, Lyon A R, Harbinson M T, Hanna G G
机构信息
The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London.
National Heart and Lung Institute, Imperial College London; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London.
出版信息
Ulster Med J. 2017 Jan;86(1):3-9.
More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the issues of cancer survivorship, awareness of the management of cardiac toxicity would be prudent for all physicians looking after patients with cancer.
1960年以后出生的人，超过半数在一生中会患上癌症。幸运的是，由于诊断和治疗水平的提高，在过去三十年中治愈率稳步上升。随着生存率的提高，更多的人将经历癌症治疗对心脏产生的不良反应。由于肿瘤学家的关注点开始涵盖癌症幸存者的问题，对于所有照料癌症患者的医生而言，了解心脏毒性的管理方法是明智之举。
Zotero 插件